Tirzepatide 10mg vial, 4 weeks/1month supply + inj. water

VLS Semaglutide is an FDA-approved GLP-1 medication that is injected under the skin using a insulin needle once a week (every seven days), day or night, with or without food.

VLS Semaglutide speeds up the weight loss process for many patients. However, like other medical weight loss diets, what you eat, exercise, lifestyle changes, and time will help determine the overall success of your weight loss journey.

VLS Semaglutide is an injectable prescription medicine used:

• along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus.
• to reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes mellitus with known heart disease

VLS Tirzepatide for Weightloss:

• FDA approved in 2023
• Up to 24.6% weight loss over 72 week trials
• Powerful apetite suppresant
• Regulates blood sugar
• Can help improve cardiovascular risk factors
• Improves lipid levels

Q: What is VLS Tirzepatide?

Tirzepatide (VLS brand) is used for weight loss, to help lose weight and keep weight off. Tirzepatide works for weight loss by decreasing appetite and slowing the movement of food from the stomach into the small intestine, which may make you feel full more quickly and for a longer period of time. Tirzepatide is a once-weekly injection given under the skin using a pen (autoinjector).

Q: When should I not use VLS Tirzepatide?

Do not use Tirzepatide if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).

Do not use Tirzepatide if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Do not use Tirzepatide if you are allergic to it or any of the ingredients in Tirzepatide.

Q: How should I use VLS Tirzepatide?

Full injection guide is available here.

Use VLS Semaglutide exactly as your healthcare provider tells you to.

• VLS Semaglutide is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm. Do not inject VLS Semaglutide into a muscle (intramuscularly) or vein (intravenously).
• Use VLS Semaglutide 1 time each week, on the same day each week, at any time of the day.
• You may change the day of the week you use VLS Semaglutide as long as your last dose was given 2 or more days before.
• If you miss a dose of VLS Semaglutide, take the missed dose as soon as possible within 5 days after the missed dose. If more than 5 days have passed, skip the missed dose and take your next dose on the regularly scheduled day.
• VLS Semaglutide may be taken with or without food.
• Do not mix insulin and VLS Semaglutide together in the same injection.
• You may give an injection of VLS Semaglutide and insulin in the same body area (such as your stomach area), but not right next to each other.
• Change (rotate) your injection site with each injection. Do not use the same site for each injection.
• Check your blood sugar as your healthcare provider tells you to.
• Stay on your prescribed diet and exercise program while using VLS Semaglutide.
• Talk to your healthcare provider about how to prevent, recognize and manage low blood sugar(hypoglycemia), high blood sugar (hyperglycemia), and problems you have because of your diabetes.
• Your healthcare provider will check your diabetes with regular blood tests, including your blood sugar levels and your hemoglobin A1C.
• Do not share your VLS Semaglutide pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
• Your dose of VLS Semaglutide and other diabetes medicines may need to change because of change in level of physical activity or exercise, weight gain or loss, increased stress, illness, change in diet, fever, trauma, infection, surgery or because of other medicines you take.
• If you take too much VLS Semaglutide, call your healthcare provider or go to the nearest hospital emergency room right away.

Q: What are the possible side effects of VLS Tirzepatide?

VLS Tirzepatide may cause serious side effects, including:

Inflammation of your pancreas(pancreatitis): Stop using VLS Tirzepatide and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.

Changes in vision: Stop using VLS Tirzepatide and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.

Low blood sugar(hypoglycemia): Your risk for getting low blood sugar may be higher if you use VLS Tirzepatide with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability, or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, feeling jittery.

Kidney problems (kidney failure): In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration. Serious allergic reactions: Stop using VLS Tirzepatide and get medical help right away, if you have any symptoms of a serious allergic reaction including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy or very rapid heartbeat.

Gallbladder problems: Gallbladder problems have happened in some people who take VLS Tirzepatide .Tell your healthcare provider right away if you get symptoms of gallbladder problems which may include pain in your upper stomach (abdomen), yellowing of skin or eyes (jaundice), fever or clay-colored stools.

The most common side effects of VLS Tirzepatide may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation. Talk to your healthcare provider about any side effect that bothers you or does not go away. These are not all the possible side effects of VLS Tirzepatide.

Initial dose:

Weeks 1 through 4: 0.25 mg subcutaneously once a week

Weeks 5 through 8: 0.5 mg subcutaneously once a week

Weeks 9 through 12: 1 mg subcutaneously once a week

Weeks 13 through 16: 1.5 mg subcutaneously once a week

Maintenance dose:

Week 17 and onward: 2.5 mg subcutaneously once a week